These tests, conducted in a separate cohort, were designed to assess generalizability across related incretin-based compounds and may inform the clinical use and continued development of GLP-1-based therapies for AUD, while also serving as a foundation for future studies evaluating compound- and receptor-specific mechanisms
Our mission is to help you optimize your life from the inside out, providing you with fine-tuned, personalized programs that cater to your unique needs
Primary endpoint: composite MACE (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke)
Yes, BPC-157 is often combined with other regenerative therapies such as TB-500 (for enhanced tissue repair), physical therapy, proper nutrition, and other peptides depending on your specific goals